Wilmington, Delaware, United States
Michael O’Laughlin, is President and Founder, O’Laughlin & Associates, a health care strategy consulting firm, in Wilmington, Delaware.
With with over 25 years experience in marketing, medical education, medical publishing, and brand management, Michael provides management consulting, strategic marketing, and drug development consulting to biopharmaceutical firms, health care communication firms and leading universities.
Michael has extensive experience developing brand strategies, and strategic communication plans for therapies to treat complex chronic diseases. On a national basis, he has worked with academia, medical associations, patient advocacy groups and managed care organizations to communicate information about new treatments for diseases in oncology, neurology, cardiology and gastroenterology.
Michael has a deep understanding of current and emerging biopharmaceutical markets by therapeutic class. Additionally, he understands the changing health care environment and matrix of factors that will change how health care is delivered. He routinely monitors developments in health care policy, health information technology, quality and safety issues. All these factors will impact the commercial viability and success of current and future treatments.
Michael was Vice President/Account Director at GSW-Worldwide where he managed a team that worked with Ortho-McNeil Neurologics on their Alzheimer’s disease drug, RAZADYNE® ER.
Prior to GSW, Michael spent 17 years at AstraZeneca and legacy companies, where he led the development and execution of strategic marketing plans for SEROQUEL®, PLENDIL® , and PRILOSEC®. Under his leadership he led the launch of TOPROL-XL® for a new indication (heart failure), while expanding market share in hypertension and angina markets. In just 3½ years TOPROL-XL became the most prescribed drug by cardiologists, exceeding two million prescriptions per month and $1 billion in annual sales.
Michael began his career as a sales representative in the Chicago area. He currently lives in Wilmington, Delaware.